DNA INTERSTRAND CROSS-LINKING BY 2,5-BIS(1-AZIRIDINYL)-1,6-BENZOQUINONE - NUCLEOTIDE-SEQUENCE PREFERENCES AND COVALENT STRUCTURE OF THE DG-TO-DG CROSS-LINKS AT 5'-D(GN(N)C) IN SYNTHETIC OLIGONUCLEOTIDE DUPLEXES

被引:27
作者
ALLEY, SC [1 ]
BRAMELD, KA [1 ]
HOPKINS, PB [1 ]
机构
[1] UNIV WASHINGTON,DEPT CHEM,SEATTLE,WA 98195
关键词
D O I
10.1021/ja00086a006
中图分类号
O6 [化学];
学科分类号
0703 ;
摘要
The nucleotide sequence specificity of the DNA interstrand cross-linking reaction of 2,5-bis(1-aziridinyl)1,4-benzoquinone (DZQ) and the covalent structure of the predominant cross-link were determined in synthetic DNA duplexes. A panel of synthetic DNAs was exposed to aqueous DZQ and analyzed for interstrand cross-links by denaturing polyacrylamide gel electrophoresis (DPAGE). Those containing the sequences 5'-d(GGCC), 5'-d(GGGCCC), and 5'-d(GGGGC) afforded relatively abundant interstrand cross-linked products. Exposure of some of these DZQ-cross-linked DNAs to hot aqueous piperidine followed by DPAGE analysis afforded DNA strand scission products with mobility identical to that of the products of the Maxam-Gilbert G reaction, consistent with a dG-to-dG nucleotide connectivity at the duplex sequences 5'-d(GN(n)C), n = 0, 1, and 2, with some preference for n = 1. The covalent structure of the cross-link was assigned by a combination of spectroscopic measurements and chemical reactions as bridging N-7 atoms of dG residues on opposite strands of DNA through an intervening 2,5-bis(ethyleneamino)-1,4-benzoquinone unit. The origin of the nucleotide sequence preference of DZQ is discussed.
引用
收藏
页码:2734 / 2741
页数:8
相关论文
共 59 条
[1]  
ANSLOW WP, 1947, J PHARMACOL EXP THER, V91, P224
[2]   NOVEL INTERSTRAND CROSS-LINKS INDUCED BY THE ANTITUMOR ANTIBIOTIC CARZINOPHILIN AZINOMYCIN-B [J].
ARMSTRONG, RW ;
SALVATI, ME ;
NGUYEN, M .
JOURNAL OF THE AMERICAN CHEMICAL SOCIETY, 1992, 114 (08) :3144-3145
[3]  
Arnott S., 1976, HDB BIOCHEMISTRY MOL, VII, P411
[4]   2 STRUCTURALLY RELATED DIAZIRIDINYLBENZOQUINONES PREFERENTIALLY CROSS-LINK DNA AT DIFFERENT SITES UPON REDUCTION WITH DT-DIAPHORASE [J].
BERARDINI, MD ;
SOUHAMI, RL ;
LEE, CS ;
GIBSON, NW ;
BUTLER, J ;
HARTLEY, JA .
BIOCHEMISTRY, 1993, 32 (13) :3306-3312
[5]   PHASE-I PHASE-II TRIAL AND PHARMACOKINETICS OF INTRATHECAL DIAZIQUONE IN REFRACTORY MENINGEAL MALIGNANCIES [J].
BERG, SL ;
BALIS, FM ;
ZIMM, S ;
MURPHY, RF ;
HOLCENBERG, J ;
SATO, J ;
REAMAN, G ;
STEINHERZ, P ;
GILLESPIE, A ;
DOHERTY, K ;
POPLACK, DG .
JOURNAL OF CLINICAL ONCOLOGY, 1992, 10 (01) :143-148
[6]  
BLOOMFIELD VA, 1974, PHYSICAL CHEM NUCLEI
[7]  
Borer PN, 1975, CRC HDB BIOCH MOL BI, V1, P589
[8]   REACTION OF MONO- AND DI-FUNCTIONAL ALKYLATING AGENTS WITH NUCLEIC ACIDS [J].
BROOKES, P ;
LAWLEY, PD .
BIOCHEMICAL JOURNAL, 1961, 80 (03) :496-&
[9]   ALKYLATION OF GUANOSINE AND GUANYLIC ACID [J].
BROOKES, P ;
LAWLEY, PD .
JOURNAL OF THE CHEMICAL SOCIETY, 1961, (SEP) :3923-&
[10]   THE ALKYLATION OF DNA INVITRO BY 2,5-BIS(2-HYDROXYETHYLAMINO)-3,6-DIAZIRIDINYL-1,4-BENZOQUINONE (BZQ) .1. [J].
BUTLER, J ;
HOEY, BM ;
WARD, TH .
BIOCHEMICAL PHARMACOLOGY, 1989, 38 (06) :923-927